CCS
Century Communities, Inc.
CCS trails on the overall score without a compensating advantage in the available component scores.
NIO
NIO Inc.
NIO has the edge over CCS overall, supported by stronger fundamentals and stronger valuation.
CCS Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Stable | |
| Under pressure | |
| Stable |
CCS's profitability and balance sheet are currently stable, but its revenue and cash flow are under pressure.
NIO Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Stable | |
| Stable | |
| Unavailable |
NIO's revenue is currently strong, and its profitability and cash flow are stable. There isn't enough data to rate its balance sheet.
CCS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 4.2x | $15.75 | -70% |
| Fair | 8x | $29.98 | -42% |
| Expensive | 11x | $39.91 | -23% |
| Current | 14x | $51.92 | — |
| Forward | 27x | $51.92 | — |
Historical ranges are pointers, not guarantees.
CCS's PE is in its expensive range at 14x. Analysts expect earnings to fall, which would put today's price at 27x next year's earnings.
NIO PE Valuation
NIO has no meaningful PE right now: it lost money over the past year.
CCS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong decline | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect CCS's earnings and profitability to decline, with its revenue holding steady.
NIO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
NIO has the edge over CCS on the outlook, with more favorable earnings and revenue expectations.
CCS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.89 | -50% |
| Q3 2026 | $3.75 | -45% |
| Q2 2026 | $4.56 | -44% |
| Q1 2026 | $4.44 | -54% |
| Q4 2025 | $4.86 | -53% |
| Q3 2025 | $6.85 | -32% |
| Q2 2025 | $8.19 | -18% |
| Q1 2025 | $9.66 | +7.2% |
| Q4 2024 | $10.40 | +29% |
CCS has the edge over NIO on earnings quality, reporting a profit while its opponent remains loss making.
NIO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$0.29 | +$1.45 |
| Q1 2026 | -$0.60 | +$1.16 |
| Q4 2025 | -$1.06 | +$0.60 |
| Q3 2025 | -$1.59 | +$0.02 |
| Q2 2025 | -$1.74 | -$0.10 |
| Q1 2025 | -$1.76 | +$0.06 |
| Q4 2024 | -$1.66 | +$0.21 |
| Q3 2024 | -$1.61 | +$0.32 |
NIO is still losing money, but far less than before: $0.29 per share over the past year, against $1.93 at its worst in late 2023.
CCS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $864.5M | -12% |
| Q2 2026 | $927.2M | -7.3% |
| Q1 2026 | $789.7M | -13% |
| Q4 2025 | $1.2B | -3.1% |
| Q3 2025 | $980.3M | -14% |
| Q2 2025 | $1B | -3.7% |
| Q1 2025 | $903.2M | -4.8% |
| Q4 2024 | $1.3B | +5.6% |
CCS's revenue has slid since its 2024 peak: $864M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 1.8% | -3 points |
| Q2 2026 | 5.3% | +0.6 points |
| Q1 2026 | 4.2% | -1.6 points |
| Q4 2025 | 3.8% | -6.8 points |
| Q3 2025 | 4.9% | -4.8 points |
| Q2 2025 | 4.7% | -5.9 points |
| Q1 2025 | 5.8% | -3.1 points |
| Q4 2024 | 11% | +0.2 points |
CCS has the edge over NIO on profitability, with a higher operating margin.
NIO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.8B | +69% |
| Q1 2026 | $3.8B | +112% |
| Q4 2025 | $5.2B | +76% |
| Q3 2025 | $3.3B | +17% |
| Q2 2025 | $2.9B | +9% |
| Q1 2025 | $1.8B | +21% |
| Q4 2024 | $3B | +15% |
| Q3 2024 | $2.8B | -2.1% |
NIO has the edge over CCS on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -2.1% | +24 points |
| Q1 2026 | -1.2% | +52 points |
| Q4 2025 | 2.3% | +33 points |
| Q3 2025 | -16% | +12 points |
| Q2 2025 | -26% | +4 points |
| Q1 2025 | -53% | +1.1 points |
| Q4 2024 | -31% | +8.1 points |
| Q3 2024 | -28% | -2.6 points |
NIO's operating margin was −2.1% last quarter, up 24 points from the same quarter a year ago.
CCS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$142.4M | -$121.6M |
| Q2 2026 | -$89.6M | -$72.1M |
| Q1 2026 | -$57.1M | -$17.1M |
| Q4 2025 | $202.6M | -30% |
| Q3 2025 | -$20.8M | +$81.1M |
| Q2 2025 | -$17.6M | +$100.1M |
| Q1 2025 | -$40M | -355% |
| Q4 2024 | $290.6M | +$310.6M |
CCS has burned cash in six of the last eight quarters: −$87M over the past year, against $212M the year before.
NIO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $0 | +$2.1B |
| Q1 2026 | $0 | $0 |
| Q4 2025 | $0 | +$391.3M |
| Q3 2025 | $0 | $0 |
| Q2 2025 | -$2.1B | +$73.9M |
| Q1 2025 | $0 | $0 |
| Q4 2024 | -$391.3M | -386% |
| Q2 2024 | -$2.2B | +$337.9M |
NIO has the edge over CCS on cash flow, with more consistent year-over-year improvement.
CCS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.2x | Moderate |
| Q2 2026 | 1.2x | Healthy |
| Q1 2026 | 0.6x | Very low |
| Q4 2025 | -0.3x | Net Cash |
| Q3 2025 | 0.7x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.3x | Very low |
| Q4 2024 | -0.0x | Net Cash |
CCS's net debt is about 2.2 years of its operating earnings (EBITDA), up from less than a year a year ago.
NIO Net Leverage
NIO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CCS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 39.0 | Neutral |
| Stochastic | 12.1 | Oversold |
CCS's weekly RSI is 39 (neutral) and its Stochastic is 12 (oversold).
NIO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 30.7 | Neutral |
| Stochastic | 6.9 | Oversold |
NIO's weekly RSI is 31 (neutral) and its Stochastic is 7 (oversold).
CCS PE vs Consumer Cyclical Sector
| Metric | CCS | Sector median | Relative |
|---|---|---|---|
| PE | 14x | 18x | 23% below |
| PE % | 95 | 47 | 48 pts above |
CCS is trading at 14x earnings, a 23% discount to the Consumer Cyclical sector's median of 18x.
NIO PE vs Consumer Cyclical Sector
NIO has no meaningful PE right now: it lost money over the past year.
CCS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $56.3 | 7.8% below |
| 20 week MA | $62.7 | 17% below |
| 50 week MA | $61.8 | 16% below |
| 100 week MA | $62.7 | 17% below |
| 200 week MA | $70.9 | 27% below |
CCS is in a downtrend: it's below all five of its weekly moving averages, and 27% below its 200-week average.
NIO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.36 | 9.2% below |
| 20 week MA | $4.01 | 24% below |
| 50 week MA | $4.81 | 37% below |
| 100 week MA | $4.85 | 37% below |
| 200 week MA | $6.03 | 49% below |
NIO is in a downtrend: it's below all five of its weekly moving averages, and 49% below its 200-week average.
CCS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $27.3 | $47.5 | +74% |
| 2021 | $47.5 | $79.5 | +67% |
| 2022 | $79.5 | $51.4 | -35% |
| 2023 | $51.4 | $91.1 | +77% |
| 2024 | $91.1 | $73.6 | -19% |
| 2025 | $73.6 | $59.0 | -20% |
| 2026 YTD | $59.0 | $51.9 | -12% |
CCS has the edge over NIO on returns for 2026, with the stronger performance.
NIO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2.42 | $45.8 | +1791% |
| 2021 | $45.8 | $30.5 | -33% |
| 2022 | $30.5 | $11.0 | -64% |
| 2023 | $11.0 | $9.07 | -17% |
| 2024 | $9.07 | $4.48 | -51% |
| 2025 | $4.48 | $5.10 | +14% |
| 2026 YTD | $5.10 | $3.05 | -40% |
NIO's yearly returns have swung widely, from +1791% in 2020 to −64% in 2022. It's down 40% so far in 2026.